Unravel Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Unravel Biosciences's estimated annual revenue is currently $1.2M per year.
- Unravel Biosciences's estimated revenue per employee is $77,500
Employee Data
- Unravel Biosciences has 15 Employees.
- Unravel Biosciences grew their employee count by 25% last year.
Unravel Biosciences's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder and CSO | Reveal Email/Phone |
2 | Chief Medical Officer | Reveal Email/Phone |
3 | Senior Scientist | Reveal Email/Phone |
4 | Research Associate Rare Disease Biology | Reveal Email/Phone |
5 | Business Development Associate | Reveal Email/Phone |
Unravel Biosciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is Unravel Biosciences?
Diseases are a product of complex interactions among biological layers that we barely understand. Our platform integrates computational drug prediction with on-demand animal models and cutting-edge screening hardware to rapidly connect behavioral and cognitive symptoms to novel therapeutic targets and treatments in a matter of weeks. Unlike other discovery stage companies, Unravel enables unbiased identification of drug targets that span organ systems, including restoring metabolism and reducing inflammation.
keywords:N/AN/A
Total Funding
15
Number of Employees
$1.2M
Revenue (est)
25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.3M | 15 | -12% | N/A |
#2 | $1.3M | 15 | -17% | N/A |
#3 | $1M | 15 | 0% | $50M |
#4 | $1.8M | 15 | N/A | N/A |
#5 | $0.9M | 15 | 0% | $13.3M |